Orthopediatrics (KIDS) Cash from Investing Activities (2016 - 2026)

Orthopediatrics (KIDS) has reported Cash from Investing Activities for 11 consecutive years, with -$3.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 36.75% year-over-year to -$3.8 million; the TTM figure through Mar 2026 stood at -$41.4 million (down 167.8% YoY), while the FY2025 annual figure was -$43.6 million, down 231.48% from the prior year.
• Cash from Investing Activities climbed to -$3.8 million in Q1 2026 per KIDS's latest filing, from -$7.3 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $32.3 million in Q1 2023 and bottomed at -$103.9 million in Q3 2022.
• Historically, Cash from Investing Activities has averaged -$7.8 million across 5 years, with a median of -$3.7 million in 2024.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities jumped 355.09% — and 2023, when it sank 3351.33%.
• Orthopediatrics' Cash from Investing Activities stood at -$23.2 million in 2022, then soared by 177.16% to $17.9 million in 2023, then plunged by 113.46% to -$2.4 million in 2024, then plunged by 200.95% to -$7.3 million in 2025, then jumped by 47.83% to -$3.8 million in 2026.
• Business Quant data shows KIDS's Cash from Investing Activities at -$3.8 million in Q1 2026, -$7.3 million in Q4 2025, and -$26.8 million in Q3 2025.